Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
12/2010
12/08/2010CN101481357B Preparation of quinoxaline derivatives
12/08/2010CN101087783B Trisubstituted thiophenes as progesterone receptor modulators
12/07/2010US7846963 such as 3-[1-(2,4-Dimethoxybenzyl)-2-oxo-2,5-dihydro-1H-pyrrol-3-yl]-N-hydroxypropionamide, used for preventing and treating the inflammatory diseases, for example rheumatoid arthritis, gout, osteoarthritis, lupus, arthritis, Crohn's disease, diabetes, bursitis, burns and scaring
12/07/2010US7846959 Raf modulators and methods of use
12/07/2010US7846945 2-[4-Chloro-3-(4-hydroxy-benzyl)-phenyl]-6-methoxy-tetrahydro-pyran-3,4,5-triol; 2-[4-Chloro-3-(4-ethoxy-benzyl)-phenyl]-3,4,5-trihydroxy-piperidine-1-carboxylic acid methyl ester; (2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-methoxytetrahydro-2H-thiopyran-3,4,5-triol; antidibetic, antiobesity agents
12/07/2010US7846933 such as 1-(4-Fluorophenyl)-5-(pyridin-4-yl)-4-imidazolin-2-one, having excellent p38 MAP kinase inhibitory action, useful for the treatment of osteoarthritis, arthritis, ulcerative colitis, Crohn's disease, psoriasis, dermatitis, asthma, bronchitis, pneumonia, rhinitis, conjunctivitis or keratitis
12/07/2010US7846926 podophyllotoxin derivatives such as (2-{3-[4-(3-aminopropylamino)-butylamino]-propylamino}-N-[9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5,6,8,8a,9-hexahydrofuro[3',4':6,7]naptho[2,3-d][1,3]dioxol-5-yl]-acetamide, used as anticarcinogenic agents
12/07/2010CA2583084C 7,8-bicycloalkyl-chroman derivatives
12/07/2010CA2374995C Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
12/02/2010WO2010138790A1 Antiviral compounds composed of three aligned aryl moieties to treat diseases such as hepatitis c
12/02/2010WO2010137620A1 Phenoxyethylamine derivative
12/02/2010WO2010137484A1 Anti-shock agent comprising diaminotrifluoromethylpyridine derivative
12/02/2010WO2010137351A1 Aryl substituted carboxamide derivatives as calcium or sodium channel blockers
12/02/2010WO2010137349A1 Agent for treatment or prevention of diseases associated with activity of neurotrophic factors
12/02/2010WO2010136778A1 Dibenzothiophene derivatives as dna- pk inhibitors
12/02/2010WO2010136755A1 Substituted benzotriazines and quinoxalines as inhibitors of p7os6 kinase
12/02/2010WO2010136109A1 Materials for organic electroluminescent devices
12/02/2010WO2010136037A1 Novel calcium sensing receptor modulating compounds and pharmaceutical use thereof
12/02/2010WO2010106269A3 Derivatives of n-[(2-aza-bicyclo[2.1.1]hex-1-yl)-aryl-methyl]-heterobenzamide, preparation thereof and application of same in therapeutics
12/02/2010US20100305328 Process for preparation of piperidine carboxylic acid
12/02/2010US20100305157 derivatives of dicarboxylic amino acids and their application in the treatment of neurodegenerative diseases
12/02/2010US20100305146 Method for the Production of 1,3-Dioxolane-2-Ones and Carboxylic Acid Esters by Means of Transacylation in Basic Reaction Conditions
12/02/2010US20100305137 Piperazine derivatives and methods of use
12/02/2010US20100305095 Use of HPPD Inhibitors in the Treatment of Depression and/or Withdrawal Symptoms Associated with Addictive Drugs
12/02/2010US20100305089 Fused Bicycloheterocycle Substituted Azabicyclic Alkane Derivatives
12/02/2010US20100305088 INHIBITORS OF THE CHEMOKINE RECEPTOR CxCR3
12/02/2010US20100301313 Benzanthracene compound and organic electroluminescence device using the same
12/02/2010US20100300521 Squarylium dyes including an anchoring group
12/02/2010CA2762885A1 Antiviral compounds composed of three aligned aryl moieties to treat diseases such as hepatitis c
12/02/2010CA2762620A1 Agent for treatment or prevention of diseases associated with activity of neurotrophic factors
12/02/2010CA2762137A1 Novel calcium sensing receptor modulating compounds and pharmaceutical use thereof
12/02/2010CA2761639A1 Aryl substituted carboxamide derivatives as calcium or sodium channel blockers
12/02/2010CA2761597A1 Anti-shock agent comprising diaminotrifluoromethylpyridine derivative
12/01/2010EP2256106A1 3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinases (CDK) and glycogen synthase kinase-3 (GSK-3) modulators
12/01/2010EP2254884A2 3-alkyl-piperazine derivatives and uses thereof
12/01/2010EP2254883A1 Substituted indole derivatives
12/01/2010EP1368342B3 Benzimidazole and pyridylimidazole derivatives as ligands for gaba receptors
12/01/2010CN1993353B Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase
12/01/2010CN101903373A Functionally selective alpha2c adrenoreceptor agonists
12/01/2010CN101903372A Heteroaryl derivatives as orexin receptor antagonists
12/01/2010CN101903341A Substituted N-phenyl-bipyrrolidine ureas and therapeutic use thereof
12/01/2010CN101903339A Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
12/01/2010CN101902912A Fungicidal amines
12/01/2010CN101899006A 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents
12/01/2010CN101353327B Aryl substituted pyrimidine spirobifluorene derivative and preparation thereof
11/2010
11/30/2010US7842822 (3aS, 4S, 9bS)-4-(4-Hydroxy-phenyl)-1,3a,4,9b-tetrahydro-3H-2,5-dioxa-cyclopenta[a]naphthalen-8-ol, used for the treatment of benign prostatic hyperplasia, cardiovascular diseases, neurodegenerative disorders, incontinence, nervous system disorders, gastrointestinal disorders and osteoporosis
11/30/2010US7842820 Sulfonylpyrroles
11/30/2010US7842808 Anti-migraine spirocycles
11/30/2010US7842718 thiophene sulfonamide derivatives such as 5-Chloro-N-[(S)-2-hydroxy-1-phenylethyl]thiophene-2-sulfonamide, that inhibit the production of beta amyloid protein from amyloid precursor protein; capable of passing through the blood-brain barrier, used for treatment of Alzheimer's disease and Down's syndrome
11/30/2010US7842712 Indazolinone compositions useful as kinase inhibitors
11/30/2010US7842704 Biphenyl-2-ylcarbamic Acid 1-{9-[2-(4-Hydroxy-2-oxo-2,3-dihydrobenzothiazol-7-yl)-ethylamino]nonyl}piperidin-4-yl Ester Bis(trifluoroacetate) Salt; chronic obstructive pulmonary disease, asthma; bronchodilators
11/30/2010US7842695 such as 1-{1-[5-(4-Fluorophenyl)pyridin-2-yl]-5-furan-2-yl-1H-pyrazol-4-ylmethyl}-4-methylpiperazine, exhibiting selective serotonin receptor antagonistic properties, used for the prophylaxis and/or treatment of psychoses, neurological disorders, amyotrophic lateral sclerosis, eating and vision disorders
11/30/2010US7842693 For therapy of rheumatoid arthritis, multiple sclerosis, transplant rejection, dermnatitis, eczema, urticaria, vasculitis, inflammatory bowel disease, food allergy and encephalomyelitis
11/30/2010CA2519938C Prostaglandin analogs as ep4 receptor agonists
11/30/2010CA2515151C Non-nucleoside reverse transcriptase inhibitors
11/30/2010CA2477208C Substituted phenylalkanoic acid derivatives and use thereof
11/30/2010CA2432809C Heteroaryl urea neuropeptide y y5 receptor antagonists
11/25/2010WO2010133306A1 Process for the preparation of ibodutant (men15596) and related intermediates
11/25/2010WO2010132999A1 Methyl sulfanyl pyrmidmes useful as antiinflammatories, analgesics, and antiepileptics
11/25/2010WO2010132951A1 Oligothiophenes and uses thereof in photovoltaic devices
11/25/2010WO2010106436A3 Novel anti-inflammatory agents
11/25/2010WO2009132202A3 Macrocyclic compounds and their use as kinase inhibitors
11/25/2010WO2009116075A3 Process for preparation of tazarotene
11/25/2010US20100298562 Pyridazine and Pyrrole Compounds, Processes For Obtaining Them and Uses
11/25/2010US20100298421 Derivatives of taxol and closely related compounds
11/25/2010US20100298347 Substituted 2-naphthoic acids as antagonists of gpr105 activity
11/25/2010US20100298346 Nitrogenous heterocyclic compounds with insecticidal activity, and the preparation and use thereof
11/25/2010US20100298345 Synthetic compounds and derivatives as modulators of smoking or nicotine ingestion and lung cancer
11/25/2010US20100298301 Oxazole tyrosine kinase inhibitors
11/25/2010US20100298295 2-biphenylamino-4-aminopyrimidine derivatives as kinase inhibitors
11/25/2010US20100298284 Benzamides and related inhibitors of factor xa
11/25/2010US20100297541 Sulphonium salt initiators
11/25/2010US20100297540 Sulphonium salt initiators
11/25/2010US20100294723 Detection of negatively charged polymers using water-soluble, cationic, polythiophene derivatives
11/25/2010CA2762625A1 Process for the preparation of ibodutant (men15596) and related intermediates
11/24/2010EP2253620A1 Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors
11/24/2010EP2253614A1 Inhibitors of IAP
11/24/2010EP2253328A1 Cycloalkyl inhibitors of potassium channel function
11/24/2010EP2252600A1 Substituted triazinylmethyl sulfonamides
11/24/2010EP2252598A2 1,3-oxazepan-2-one and 1,3-diazepan-2-one inhibitors of 11beta-hydroxysteroid dehydrogenase 1
11/24/2010EP2252597A2 Novel compounds, use and preparation thereof
11/24/2010EP2252594A2 5-fluoro pyrimidine derivatives as fungicides
11/24/2010EP2252593A1 Substituted pyridazine derivatives which have histamine h3 antagonist activity
11/24/2010EP2252592A1 Arylchalcogeno-arylalkyl-substituted imidazolidine-2,4-diones, method for the production thereof, medicaments containing said compounds and use thereof
11/24/2010EP2252590A1 Substituted sulfonic acid amide compounds
11/24/2010EP2252589A2 6-and 7-amino isoquinoline compounds and methods for making and using the same
11/24/2010EP2252299A1 Fused pyridone m1 receptor positive allosteric modulators
11/24/2010EP1899330B1 Substituted glycinamides having an antithrombotic and factor xa-inhibiting effect
11/24/2010EP1501829B1 Thiadiazoles or oxadiazoles and their use as inhibitors of jak protein kinase
11/24/2010EP1497287B1 Quinoline derivatives in combination with 5-FU or CPT-11 for use in the treatment of cancer
11/24/2010EP1370260B1 Azoles as malonyl-coa decarboxylase inhibitors useful as metabolic modulators
11/24/2010CN1880304B Triamide-substituted indoles, benzofuranes and benzothiophenes
11/24/2010CN101894912A Electric conductivity adjustable organic molecular film and semiconductor hybrid material and preparation method thereof
11/24/2010CN101891680A Modulators of atp-binding cassette transporters
11/23/2010US7838549 adding three or more sugars with high reproducibility, disulfide bond immobilized on protein-analyzing sensor chip; oligoethylene oxide group enables linker cmpd to minimize nonspecific hydrophobic interaction; metal-sulfur bond; 1,2-dithiolane on tri-branched amino acid attached to oligosaccharide; SPR
11/23/2010US7838537 Viral polymerase inhibitors
11/23/2010US7838530 Antiproliferative agent in the prevention or treatment of tumors which are sensitive to inhibition of EGF and erbB receptor tyrosine kinases;1-({4-[(3-chloro-2-fluorophenyl)amino]-7-methoxyquinazolin-6-yl}methyl)-L-prolinamide
11/23/2010US7838527 Methods of treating cancer and related methods
11/23/2010US7838525 modulators of glucose metabolism, GPCR, RUP3; metabolic disorders and complications thereof such as diabetes and obesity; 4-[5-Cyano-6-(6-methylsulfanyl-pyridin-3-ylamino)-pyrimidin-4-yloxy]-piperidine-1-carboxylic acid tert-butyl ester
11/23/2010US7838520 Inhibitors of histone deacetylase
1 ... 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 ... 523